Publication | Open Access
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer
171
Citations
29
References
2013
Year
Surgical OncologySerum Carbohydrate AntigenPancreatic CancerNeoadjuvant TherapyGastrointestinal OncologyMedicineImmunologyPathologyPancreatic SurgeryOncologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1